Publication: Cervical cancer screening guidelines: An updated review
dc.contributor.author | Suwicha Chittithaworn | en_US |
dc.contributor.author | Chuenkamon Charakorn | en_US |
dc.contributor.author | Chompunoot Kongsawatvorakul | en_US |
dc.contributor.other | Ramathibodi Hospital | en_US |
dc.date.accessioned | 2022-08-04T09:18:51Z | |
dc.date.available | 2022-08-04T09:18:51Z | |
dc.date.issued | 2021-07-01 | en_US |
dc.description.abstract | Screening is one of the strategies for cervical cancer elimination. Since the beginning of cytology to the modern era of primary HPV screening, there were various different clinical guidelines. All of the guidelines aim to detect preinvasive lesion that leads to cervical cancer; however, each guideline has dissimilar recommendation with explicable reason lying underneath. To be able to choose the suitable method of screening for individual patient would be advantage in both oncologic outcome and cost-effectiveness. This review was written to summarize the detail of changes and differences through clinician's point of view. | en_US |
dc.identifier.citation | Thai Journal of Obstetrics and Gynaecology. Vol.29, No.4 (2021), 186-190 | en_US |
dc.identifier.issn | 26730871 | en_US |
dc.identifier.issn | 08576084 | en_US |
dc.identifier.other | 2-s2.0-85114408612 | en_US |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/78050 | |
dc.rights | Mahidol University | en_US |
dc.rights.holder | SCOPUS | en_US |
dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85114408612&origin=inward | en_US |
dc.subject | Medicine | en_US |
dc.title | Cervical cancer screening guidelines: An updated review | en_US |
dc.type | Review | en_US |
dspace.entity.type | Publication | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85114408612&origin=inward | en_US |